Collectively, our findings and the findings from other complementary studies indicate that across many tumour types platinum compounds and taxanes are the preferred chemotherapy partners for PD-1/PD-L1 ICIs, highlighting that these observations are translatable to other malignancies and might be a pan-cancer phenomenon. Here, CD274 is linked to neoplasm.